falsefalse

Clinical Advances in Nasopharyngeal Carcinoma - Episode 11

Clinical Scenario: Metastatic EBV-Positive NPC

, ,

The panel provides clinical insights on the treatment of a patient with metastatic EBV-positive nasopharyngeal carcinoma.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
    EP. 1: Differentiating Nasopharyngeal Carcinoma from Other Head & Neck Cancers: The Value of a Multidisciplinary Approach
    EP. 2: Current Guidelines for Managing Nasopharyngeal Carcinoma
    EP. 3: Overview of the JUPITER and POLARIS-2 Trials
    EP. 4: Value of PD-L1 Biomarker in NPC
    EP. 5: Phase 3 DIPPER Trial: Adjuvant PD-1 Blockade with Camrelizumab
    EP. 6: Tailoring NPC Treatment: Patient Populations, EBV Titer Monitoring, and Key External Factors
    EP. 7: Strategies to Mitigate Adverse Events in Nasopharyngeal Carcinoma Treatment
    EP. 8: Future Research Needs for Neoadjuvant/Adjuvant PD-1 Blockade in Nasopharyngeal Carcinoma
    EP. 9: Integrating PD-1 Inhibitors into Standard NPC Treatment: Potential Benefits and Future Prospects
    EP. 10: Clinical Scenario: Locally Recurrent NPC
    Now Viewing
    EP. 11: Clinical Scenario: Metastatic EBV-Positive NPC

    Related Content:

    Clinical Advances in Nasopharyngeal CarcinomaYale Cancer CenterCity of HopeHead & Neck CancersInsightsVideo Series
    Outpatient CAR T-Cell Therapy for R/R DLBCL: Opportunities, Challenges, and Solutions
    Overview of iMMagine-1 Trial: Phase 2 Registrational Study of Anitocabtagene Autoleucel for the Treatment of R/R MM
    Safety Considerations for CAR T-Cell Therapy in R/R DLBCL
    x